ZA945238B - 1,5 Benzodiazepine derivatives. - Google Patents

1,5 Benzodiazepine derivatives.

Info

Publication number
ZA945238B
ZA945238B ZA945238A ZA945238A ZA945238B ZA 945238 B ZA945238 B ZA 945238B ZA 945238 A ZA945238 A ZA 945238A ZA 945238 A ZA945238 A ZA 945238A ZA 945238 B ZA945238 B ZA 945238B
Authority
ZA
South Africa
Prior art keywords
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
ZA945238A
Other languages
English (en)
Inventor
Daniele Donati
Antonella Ursini
Mauro Corsi
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of ZA945238B publication Critical patent/ZA945238B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/121,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA945238A 1993-07-20 1994-07-18 1,5 Benzodiazepine derivatives. ZA945238B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314981A GB9314981D0 (en) 1993-07-20 1993-07-20 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA945238B true ZA945238B (en) 1995-02-09

Family

ID=10739096

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945238A ZA945238B (en) 1993-07-20 1994-07-18 1,5 Benzodiazepine derivatives.

Country Status (32)

Country Link
US (1) US5716953A (cs)
EP (1) EP0710230B1 (cs)
JP (1) JP3587849B2 (cs)
KR (1) KR100347287B1 (cs)
CN (1) CN1050835C (cs)
AP (1) AP492A (cs)
AT (1) ATE171167T1 (cs)
AU (1) AU687858B2 (cs)
CA (1) CA2167308A1 (cs)
CO (1) CO4290299A1 (cs)
CZ (1) CZ290472B6 (cs)
DE (1) DE69413405T2 (cs)
DK (1) DK0710230T3 (cs)
EC (1) ECSP941120A (cs)
ES (1) ES2123812T3 (cs)
FI (1) FI960223A7 (cs)
GB (1) GB9314981D0 (cs)
HR (1) HRP940411B1 (cs)
HU (1) HU222439B1 (cs)
IL (1) IL110366A (cs)
IS (1) IS4190A (cs)
MY (1) MY118638A (cs)
NO (1) NO313288B1 (cs)
NZ (1) NZ271075A (cs)
PE (1) PE8295A1 (cs)
PL (1) PL175609B1 (cs)
RU (1) RU2135485C1 (cs)
SI (1) SI0710230T1 (cs)
SV (1) SV1994000031A (cs)
TW (1) TW290542B (cs)
WO (1) WO1995003285A1 (cs)
ZA (1) ZA945238B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
WO1998002419A1 (fr) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation de cellules cancereuses
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
PT1224175E (pt) 1999-10-15 2004-07-30 Hoffmann La Roche Derivados de benzodiazepina como antagonistas do receptor de glutamato metabotropico
US20050192265A1 (en) * 2003-03-20 2005-09-01 Thompson Richard C. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
HUE025548T2 (en) * 2003-10-06 2016-02-29 Hoffmann La Roche Substituted dibenzo-azepine and benzodiazepine derivatives useful as gamma-secretase inhibitors
US8128692B2 (en) * 2004-02-27 2012-03-06 Aortx, Inc. Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same
AU2008240802B2 (en) * 2007-04-19 2012-07-05 F. Hoffmann-La Roche Ag Dihydro-benzo[B][1,4]diazepin-2-one sulfonamide derivatives
RU2540464C2 (ru) * 2012-05-28 2015-02-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Водорастворимое производное амида салициловой кислоты, обладающее транквилизирующей, ноотропной и анальгезирующей активностью
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
RU2702359C1 (ru) * 2019-06-04 2019-10-08 Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103745A1 (de) * 1971-01-27 1972-08-10 CH. Boehringer Sohn, 6507 Ingelheim Neue 5-AryJ-(bzw. Heteroaryl)-3-hydroxylH-l,5-benzodiazepin-2,4-(3H,5H)-dioneund Verfahren zu ihrer Herstellung
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9201181D0 (en) * 1992-01-21 1992-03-11 Glaxo Spa Chemical compounds
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives

Also Published As

Publication number Publication date
MY118638A (en) 2004-12-31
CN1138853A (zh) 1996-12-25
IS4190A (is) 1995-01-21
JP3587849B2 (ja) 2004-11-10
US5716953A (en) 1998-02-10
FI960223A0 (fi) 1996-01-17
TW290542B (cs) 1996-11-11
CZ290472B6 (cs) 2002-07-17
RU2135485C1 (ru) 1999-08-27
HRP940411B1 (en) 2000-12-31
HU9600124D0 (en) 1996-03-28
GB9314981D0 (en) 1993-09-01
DE69413405D1 (de) 1998-10-22
PL312659A1 (en) 1996-04-29
CO4290299A1 (es) 1996-04-17
DE69413405T2 (de) 1999-04-15
ATE171167T1 (de) 1998-10-15
NO313288B1 (no) 2002-09-09
EP0710230B1 (en) 1998-09-16
AU687858B2 (en) 1998-03-05
DK0710230T3 (da) 1999-06-14
AU7458994A (en) 1995-02-20
CN1050835C (zh) 2000-03-29
FI960223A7 (fi) 1996-03-19
NO960237D0 (no) 1996-01-19
IL110366A0 (en) 1994-10-21
ES2123812T3 (es) 1999-01-16
CA2167308A1 (en) 1995-02-02
EP0710230A1 (en) 1996-05-08
NO960237L (no) 1996-03-19
HRP940411A2 (en) 1997-04-30
ECSP941120A (es) 1995-01-16
AP492A (en) 1996-05-13
PE8295A1 (es) 1995-04-20
SV1994000031A (es) 1995-10-04
SI0710230T1 (en) 1999-02-28
WO1995003285A1 (en) 1995-02-02
HU222439B1 (hu) 2003-07-28
KR100347287B1 (ko) 2002-12-06
NZ271075A (en) 1998-06-26
AP9400657A0 (en) 1994-07-31
CZ17396A3 (en) 1996-07-17
JPH09502428A (ja) 1997-03-11
HUT73499A (en) 1996-08-28
PL175609B1 (pl) 1999-01-29
IL110366A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
ZA942570B (en) 1,5 benzodiazepine derivatives
PH30894A (en) 1,5-Benzodiazepine derivative.
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
DE59403259D1 (en) Tetraaroxyperylen-3,4,9,10-tetracarbonsäurepolyimide
ZA94335B (en) 2,6-Diaminopurine derivatives.
IL141908A0 (en) 1,4-benzodiazepine derivatives
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA941137B (en) Substitutet azolone derivatives.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
ZA945238B (en) 1,5 Benzodiazepine derivatives.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
AP9500731A0 (en) 1,5 benzodiazepine derivatives
GB2311779B (en) 2,3 benzodiazepine derivatives
ZA946569B (en) 1,5-Diphenyl-3-pyrazolylalkyl-N-hydroxydithiocarbamates
EP0710107A4 (en) DERIVATIVES OF N, N, N-TRIMETHYLSPHINGOSINE
ZA967741B (en) Diarylalkenylamine derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
ZA964034B (en) N-aminopyridone derivatives.
SG43383A1 (en) N n-diethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2- propanamine dimaleate
EP0657435A3 (de) 1,2-Dihydro-2-oxo-pyridine.
IL110556A0 (en) 7 alpha-amino-1, 1-dioxocephem l- valylamides
ZA941763B (en) Carpaine derivatives.
HU9402902D0 (en) 1,2-dihydro-2-oxo-3-methyl-sulfonyl-aminomethyl-pyridine derivatives